BioArctic AB (publ) (BIOA-B) — Cash Flow-to-Debt Ratio
BioArctic AB (publ) (BIOA-B) has a Cash Flow-to-Debt Ratio of -0.34x as of March 2026, meaning its operating cash flow of Skr-166.00 Million could theoretically repay 0% of its total liabilities (Skr481.21 Million) in one year. See BIOA-B FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BioArctic AB (publ) Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for BioArctic AB (publ) across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of BioArctic AB (publ).
Annual Cash Flow-to-Debt Ratio for BioArctic AB (publ) (2015–2025)
Year-by-year debt coverage analysis for BioArctic AB (publ). Check BioArctic AB (publ) cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 2.35x | Skr1.43 Billion | Skr608.14 Million | ▲ +261.2% |
| 2024 | -1.46x | Skr-316.33 Million | Skr216.74 Million | ▼ -165.7% |
| 2023 | 2.22x | Skr309.69 Million | Skr139.50 Million | ▲ +605.7% |
| 2022 | -0.44x | Skr-31.64 Million | Skr72.06 Million | ▲ +65.9% |
| 2021 | -1.29x | Skr-140.46 Million | Skr109.05 Million | ▼ -99.5% |
| 2020 | -0.65x | Skr-92.34 Million | Skr143.01 Million | ▼ -141.2% |
| 2019 | 1.57x | Skr327.17 Million | Skr208.84 Million | ▲ +393.9% |
| 2018 | -0.53x | Skr-200.06 Million | Skr375.31 Million | ▼ -98.7% |
| 2017 | -0.27x | Skr-135.33 Million | Skr504.35 Million | ▼ -125.7% |
| 2016 | 1.04x | Skr675.13 Million | Skr647.22 Million | ▲ +244.9% |
| 2015 | -0.72x | Skr-16.43 Million | Skr22.83 Million | — |